With cancer progression, DNM2 expression decreases through an unidentified mechanism leading to low or no expression in high-grade lesions (CIN grades 2 and 3) especially, in case of deep tumor invasion and lymph node metastasis [38, 39]. The gene discussed is DNM2; the disease is cancer.